Arcadia Biosciences, Inc.
RKDA
$3.15
$0.155.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.54M | -2.02M | -7.04M | -5.83M | -6.78M |
| Total Depreciation and Amortization | 473.00K | 654.00K | 765.00K | 816.00K | 926.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.55M | -5.09M | -1.91M | -4.37M | -4.52M |
| Change in Net Operating Assets | -2.07M | -1.55M | -1.45M | -2.18M | -2.33M |
| Cash from Operations | -7.58M | -8.01M | -9.63M | -11.56M | -12.70M |
| Capital Expenditure | 0.00 | -3.00K | -16.00K | -16.00K | -16.00K |
| Sale of Property, Plant, and Equipment | 172.00K | 317.00K | 334.00K | 415.00K | 240.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.27M | 7.52M | 7.02M | 4.48M | 4.48M |
| Cash from Investing | 3.45M | 7.84M | 7.34M | 4.88M | 4.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00K | 9.00K | 9.00K | 9.00K | 12.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 9.00K | 9.00K | 9.00K | 9.00K | 12.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.13M | -158.00K | -2.28M | -6.68M | -7.98M |